Lawmakers hold FDA foreign inspection practices under microscope at hearing without agency attendance

A sub­com­mit­tee of the House En­er­gy & Com­merce Com­mit­tee dug in­to the FDA’s for­eign in­spec­tion op­er­a­tions at a hear­ing to­day as the agency still works through a back­log of in­spec­tions from the pan­dem­ic.

The Over­sight and In­ves­ti­ga­tions Sub­com­mit­tee law­mak­ers on both sides of the aisle un­der­scored the need for con­tin­ued re­forms for for­eign in­spec­tions as the agency faces chal­lenges with fund­ing, staffing and co­or­di­nat­ing with for­eign gov­ern­ments.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.